Effectiveness and safety of adjuvant therapy of chinese herbal medicine for adenomyosis: A systematic review and meta-analysis of randomized controlled trials
- 26 November 2025
- journal article
- review article
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 81
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81273796)
- Natural Science Foundation of Sichuan Province (2023NSFSC0619)
This publication has 10 references indexed in Scilit:
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Adjuvant therapy of Chinese herbal medicine for the treatment of adenomyosisMedicine, 2020
- Systematic review and meta‐analysis of adverse pregnancy outcomes after uterine adenomyosisInternational Journal of Gynecology & Obstetrics, 2019
- Pathogenesis of uterine adenomyosis: invagination or metaplasia?Fertility and Sterility, 2018
- Social media and the intrauterine device: a YouTube content analysisBMJ Sexual & Reproductive Health, 2017
- Adenomyosis and infertilityReproductive BioMedicine Online, 2012
- Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control studyHuman Reproduction, 2010
- The symptomatology of adenomyosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Adenomyosis:Obstetrics and Gynecology Clinics of North America, 1989
- Adenomyosis: A reappraisal of symptomatologyAmerican Journal of Obstetrics and Gynecology, 1958